Trump is checked for lower leg swelling and diagnosed with a common condition in older adults
Press secretary Karoline Leavitt said tests by the White House medical unit showed that Trump has chronic venous insufficiency, which occurs when little valves inside the veins that normally help move blood against gravity gradually lose the ability to work properly.
Leavitt also addressed bruising on the back of Trump's hand, seen in recent photos covered by makeup that was not an exact match to his skin tone. She said the bruising was 'consistent' with irritation from his 'frequent handshaking and the use of aspirin.' Trump takes aspirin to reduce the risk of heart attack and stroke.
She said during her press briefing that her disclosure of Trump's medical checkup was meant to dispel recent speculation about the 79-year-old president's health. Nonetheless, the announcement was notable given that the Republican president has routinely kept secret basic facts about his health.
Trump in April had a comprehensive physical exam with more than a dozen medical specialists. The three-page report released then by the White House did not include a finding of chronic venous insufficiency. At the time, Trump's doctor, Sean Barbabella, determined that the president's joints and muscles had a full range of motion, with normal blood flow and no swelling.
Leavitt did not say when Trump first noticed the swelling in his lower legs. As part of the president's routine medical care and out of an 'abundance of caution,' she said he had a 'comprehensive exam' that included vascular, lower extremity and ultrasound testing.
She noted that chronic venous insufficiency is a benign condition that is common in people over age 70.
She said the tests revealed no evidence of deep vein thrombosis, a more serious medical condition in which a blood clot forms in one or more of the deep veins in the body, usually in the legs. Nor was there any evidence of arterial disease, she said, reading a letter from Barbabella.
People often are advised to lose weight, walk for exercise and elevate their legs periodically, and some may be advised to wear compression stockings. Severe cases over time can lead to complications including lower leg sores called ulcers. Blood clots are one cause, but was ruled out, Leavitt said.
Leavitt said the condition wasn't causing the president any discomfort. She wouldn't discuss how he was treating the condition and suggested those details would be in the doctor's letter, which was later released to the public. But the letter was the same as what she read, and it did not include any additional details.
Dr. Anahita Dua, a vascular surgeon at Mass General Brigham who has never treated Trump, said there is no cure for chronic venous insufficiency.
'The vast majority of people, probably including our president, have a mild to moderate form of it,' Dua said.
People with the condition can reduce the swelling by wearing medical-grade compression socks or stockings, to help the blood circulate back to the heart, or by walking, she said.
The exam the White House disclosed Thursday included other testing that found no signs of heart failure, renal impairment or systemic illness in Trump, Leavitt said.
'The president remains in excellent health, which I think all of you witness on a daily basis here,' she told reporters.
Superville and Neergaard write for the Associated Press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


UPI
2 hours ago
- UPI
U.S. officially withdraws from enhanced WHO pandemic response
Health workers in biohazard suits treat patients at a drive-thru coronavirus testing center at Seoul Metropolitan Eunpyeong Hospital in South Korea on March 4, 2020. The International Health Regulations Amendments approved on June 1, 2024, by the World Health Organization would allow the WHO to authorize lockdowns, travel restrictions or other measures regarding "public health risks." File Photo by Thomas Maresca/UPI | License Photo July 18 (UPI) -- The United States officially won't be involved in an enhanced pandemic global response enacted by the World Health Organization, the Trump administration said Friday. The International Health Regulations Amendments approved on June 1, 2024, would allow the WHO to authorize lockdowns, travel restrictions or other measures regarding "public health risks" but not require them. The U.S. Department of Health and Human Services said in a new release WHO would have the "ability to order global lockdowns" as part of the reforms. A total of 194 member states, including the United States, plus Liechtenstein and the Vatican negotiated the amendments. After taking office for his second term on Jan. 20, President Donald Trump officially announced the United States would pull out of WHO by January 2026. On March 20, WHO member nations by a 124-0 vote adopted the 33-page first "Pandemic Agreement" but the United States didn't participate. This separate agreement from the amendments would strengthen the global health architecture for pandemic prevention, preparedness and response." The amendments are binding Saturday if not rejected by nations, regardless of whether the United States withdraws from WHO. It was adopted by consensus without a vote of the 77th World Health Assembly. HHS Secretary Robert F. Kennedy Jr. and U.S. Secretary of State Marco Rubio issued statements on the formal rejection. Earlier, the Trump administration said it wouldn't adhere to the amendments. "The proposed amendments to the International Health Regulations open the door to the kind of narrative management, propaganda, and censorship that we saw during the COVID pandemic," Kennedy said. "The United States can cooperate with other nations without jeopardizing our civil liberties, without undermining our Constitution, and without ceding away America's treasured sovereignty." Kennedy also spoke in a video explaining the action. As did Rubio: "Terminology throughout the amendments to the 2024 International Health Regulations is vague and broad, risking WHO-coordinated international responses that focus on political issues like solidarity, rather than rapid and effective actions," Rubio said. "Our Agencies have been and will continue to be clear: we will put Americans first in all our actions and we will not tolerate international policies that infringe on Americans' speech, privacy, or personal liberties." Republicans in Congress applaud the decision. "The COVID-19 pandemic exposed how the incompetency and corruption at the WHO demands comprehensive reforms," Sen. Ron Johnson of Wisconsin said. "Instead of addressing its disastrous public health policies during COVID, the WHO wants International Health Regulation amendments and a pandemic treaty to declare public health emergencies in member states, which could include failed draconian responses like business and school closures and vaccine mandates." The amendments define what constitutes a pandemic emergency and how it can be triggered. There would also be information-sharing between countries across the world and WHO. And poorer nations would have access to medical products to "equitably address the needs and priorities of developing countries." The COVID-19 pandemic officially killed 7 million people but WHO estimates the toll to be 20 million since the virus was first detected in China in December 2019. Most nations, including the United States, are no longer tracking coronavirus cases, he said. "And on top of the human cost, the pandemic wiped more than US $10 trillion from the global economy," Tedros Adhanom Ghebreyes, the director-general of WHO, said.


New York Times
2 hours ago
- New York Times
F.D.A. to Ask Biotech Company to Stop Shipping Treatment Linked to Patient Deaths
The Food and Drug Administration will request that the biotech company Sarepta Therapeutics halt all shipments of its treatment for a deadly muscle-wasting disease after three patients died from liver failure after taking the product or a similar therapy. The troubled treatment, known as Elevidys, has fueled an ongoing debate over whether the F.D.A. has grown too lenient in approving drugs that are insufficiently safe or effective. New officials in the Trump administration, however, have rejected several new drug applications and narrowed the use of Covid vaccines over concerns about 'unknown' side effects. Elevidys, a gene therapy, is administered as a one-time intravenous infusion. It is intended to slow the progression of Duchenne muscular dystrophy, which causes muscles to deteriorate. The disease often kills patients, typically young men, before their 30th birthday. Elevidys, first approved in 2023, is one of a handful of treatments for the disease that arrived in the past decade, with the help of fierce advocacy from patients and their families. But the approval of Elevidys was controversial because of limited evidence that its benefits outweighed its risks. In recent months, two teenage boys who had received Elevidys died of liver failure, deepening critics' concerns about the drug and prompting speculation that the F.D.A. would take strict action. In late June, the F.D.A. announced an investigation into the deaths. Liver injuries were among the side effects seen in clinical trials of the treatment. On Tuesday, the company said it would halt shipments for patients with more advanced disease who use wheelchairs, a group that includes the teenagers who died and most Duchenne patients over age 12. At the time, the company planned to keep distributing the product for patients who could still walk. Want all of The Times? Subscribe.


Chicago Tribune
2 hours ago
- Chicago Tribune
UChicago Medicine to discontinue all gender-affirming pediatric care
Bowing to federal pressure under the Trump administration, UChicago Medicine has become the latest Illinois hospital to end gender-affirming pediatric care. The decision, announced Friday, leaves no room for ongoing transitional care, and an unknown number of patients in limbo. 'UChicago Medicine has reached the difficult decision that, in response to continued federal actions, it will discontinue all gender-affirming pediatric care effective immediately,' the hospital said in a statement. 'We understand that this news will have a significant impact on our patients.' The announcement by UChicago Medicine, the esteemed century-old academic medical health system based at the University of Chicago, follows a similar decision by Rush University System for Health, which 'paused' hormonal care to new patients under the age of 18 beginning July 1. Rush is continuing to offer mental and behavioral support, but referring gender care patients that need additional treatment to other providers. UChicago Medicine will no longer be on that shrinking list of hospitals providing gender-affirming pediatric care, which can include counseling, medications to delay puberty and surgery. In January, President Donald Trump issued an executive order ostensibly protecting children under 19 from 'chemical and surgical mutilation' that threatened to withhold federal research grants as well as Medicaid and Medicare reimbursement for institutions that provide such pediatric gender care services. 'We reached this conclusion in light of emerging federal actions, which would place at risk our ability to care for all Medicare or Medicaid patients,' UChicago Medicine said in its statement. 'These patients make up the majority of those we serve. As the largest Medicaid provider in Illinois, this step is necessary to ensure UChicago Medicine can continue serving our broader community and delivering on our mission.' Federal pressure to end gender-affirming pediatric care has caused several Chicago-area hospitals to curtail such services. In February, Lurie Children's Hospital paused gender-affirming surgeries for patients younger than 19, a policy which remains in place, the hospital said earlier this week. Meanwhile, UI Health allegedly canceled an Illinois teenager's gender-affirming chest surgery, according to a February federal court filing. Reached earlier this week, UI Health would not say if it was still providing gender-affirming care to minors. As for UChicago Medicine, all gender-affirming pediatric care ends Friday. 'Our focus right now is working with affected patients to discuss options going forward,' the hospital said in its statement. rchannick@